USPTO serial 79079797
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
ABDI IBRAHIM ILAÇ SANAYI VE TICARET ANONNIM SIRKETI
TR
Other trademarks owned by ABDI IBRAHIM ILAÇ SANAYI VE TICARET ANONNIM SIRKETI
ABDI IBRAHIM ILAÇ; SANAYI VE TICARET ANONIM SIRKETI
TR
Other trademarks owned by ABDI IBRAHIM ILAÇ; SANAYI VE TICARET ANONIM SIRKETI
ABDI IBRAHIM ILAÇ; SANAYI VE TICARET ANONIM SIRKETI
TR
Other trademarks owned by ABDI IBRAHIM ILAÇ; SANAYI VE TICARET ANONIM SIRKETI
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Systemic anti-infectives, including, antibacterial and antifungal pharmaceuticals; Vitamin mineral preparations, namely, vitamin and mineral supplements, vitamin and mineral preparations for medical use, vitamin preparations and mineral supplements; Musculo-skeletal system pharmaceutical products for the treatment of musculo-skeletal system diseases; Cardiovascular pharmaceuticals, including, diuretics, lipid lowering agents, beta blocking agents, calcium antagonists and other cardiovascular products; Pharmaceuticals for the prevention and treatment of disorders of the nervous system, including, analgesics, psychoanaleptics, psycoleptics, anti-epileptics, central nervous system drugs, anaesthetics, antiparkinson preparations; Pharmaceuticals for the treatment of respiratory diseases and asthma; Dermatological pharmaceutical products; Pharmaceuticals for the treatment of hormonal disorders and the prevention of osteoporosis; Anti-diabetic pharmaceuticals; Pharmaceuticals for the treatment of bone diseases and joint diseases; Pharmaceuticals for the treatment of viral and infectious diseases; Pharmaceuticals for use as antineoplastic agents; Pharmaceuticals for the treatment of immune system related diseases and disorders; Pharmaceuticals for the treatment of kidney diseases; Pharmaceuticals for the treatment of erectile dysfunction; Pharmaceuticals for ophthalmological use | SECTION 71 - CANCELLED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 28, 2020 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Aug 28, 2020 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Feb 28, 2019 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 19, 2018 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Apr 18, 2018 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Apr 18, 2018 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Apr 11, 2018 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Aug 11, 2017 | C71T | CANCELLED SECTION 71 | — |
| Feb 19, 2013 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 5, 2011 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 5, 2011 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 4, 2011 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 4, 2011 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 19, 2010 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 19, 2010 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 15, 2010 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Sep 15, 2010 | ALIE | ASSIGNED TO LIE | — |
| Sep 10, 2010 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 10, 2010 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 10, 2010 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 10, 2010 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 10, 2010 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 4, 2010 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Aug 4, 2010 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 4, 2010 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 7, 2010 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 6, 2010 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 6, 2010 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 6, 2010 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 6, 2010 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 7, 2010 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 6, 2010 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 5, 2010 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 5, 2010 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 5, 2010 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 4, 2010 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 2, 2010 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 2, 2010 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 25, 2010 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |